The reducing end of heparan sulfate has been known for a long time, but information on the non-reducing end has been lacking. Recent studies indicate that the non-reducing end of heparan sulfate might be the place where fibroblast growth factor signaling complex forms. The non-reducing end also changes with heparanase digestion and, thus, might serve as a marker for tumor pathology. Using high performance liquid chromatography-coupled mass spectrometry, we have identified and characterized the non-reducing end of bovine kidney heparan sulfate. We find that the nonreducing end region is highly sulfated and starts with a glucuronic acid (GlcA) residue. The likely sequence of the non-reducing end hexasaccharides is GlcA-GlcNS6S-UA؎2S-GlcNS؎6S-Ido2S-GlcNS؎6S (where GlcNS is N-sulfate-D-glucosamine, S is sulfate, UA is uronic acid, and Ido is iduronic acid). Our data suggests that the non-reducing end of bovine kidney heparan sulfate is not trimmed by heparanase and is capable of supporting fibroblast growth factor signaling complex formation.
Heparan sulfate (HS)2 is a long linear polysaccharide attached to core proteins in the extracellular matrix and the surface of nearly all mammalian cells. The nascent HS chain consists of disaccharide repeats of glucuronic acid (GlcA) and N-acetyl-D-glucosamine (GlcNAc) (1-3). During the process of maturation, several modifications can occur on the HS chain, which include N-deacetylation and N-sulfation of GlcNAc, epimerization of GlcA to L-iduronic acid (IdoA), 2-O sulfation of IdoA, and 6-O and 3-O sulfation of the glucosamine (GlcN). These modifications usually focus on separate regions and result in domain structures (4 -6). It is the modified domains to which various extracellular proteins bind (2, 3). The region at the reducing end of HS is usually unmodified (5, 7-9). One major function of HS is to interact with both fibroblast growth factor (FGF) and its cognate receptor and promote the FGF signaling complex formation (10 -13). Defects in HS can cause complete losses of FGF as well as Hedgehog and Wingless signaling pathways and lead to severe abnormality in embryonic development (14,15). HS also plays important roles in cell migration and cancer cell metastasis (16).Despite these known structural information and biological functions of HS, the non-reducing end (NRE) of HS has not been studied. Assuming that each HS chain has a similar content of sulfation, the fact that the reducing end of HS is devoid of sulfation (7-9, 17) suggests that the NRE of HS might be sulfated and assume biological functions. Indeed, there are indications that HS uses its NRE to direct the FGF signaling complex formation (11,13,18). Consequently, an FGF signaling complex model where two molecules each of FGF and FGF receptor bind to the NREs of two approaching HS chains has been proposed (13). Whether the NRE of HS has the ability to support the complex formation relies on its structure.It is known that heparanase activity is closely related to the metastatic potential of tumor-derived cells ...